BREAKING
Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 1 hour ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 4 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 6 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 6 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 7 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 8 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 10 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 10 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 11 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 11 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 1 hour ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 4 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 6 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 6 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 7 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 8 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 10 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 10 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 11 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 11 hours ago
ADVERTISEMENT
Market News

Earnings Summary: Humana Q3 2025 profit drops despite higher revenues

Humana Inc. (NYSE: HUM), a leading health and well-being company, on Wednesday reported a decline in adjusted earnings for the third quarter of fiscal 2025. Third-quarter earnings per share, on a reported basis, declined sharply to $1.62 from $3.98 per share in Q3 FY24 On an adjusted basis, Q3 earnings per share were $3.24, compared […]

November 5, 2025 1 min read

Humana Inc. (NYSE: HUM), a leading health and well-being company, on Wednesday reported a decline in adjusted earnings for the third quarter of fiscal 2025.

  • Third-quarter earnings per share, on a reported basis, declined sharply to $1.62 from $3.98 per share in Q3 FY24
  • On an adjusted basis, Q3 earnings per share were $3.24, compared to $4.16 per share in the year-ago quarter
  • Net income dropped to $134 million in the September quarter from $651 million a year earlier
  • The company reported total revenues of $32.6 billion for the quarter, compared to $29.4 billion last year
  • Insurance segment benefit ratio was 91.1% in Q3, in line with the company’s previously disclosed expectation of just above 91 percent
  • The management lowered its full-year earnings per share guidance to $12.26 from the previous estimate of $13.77
  • Adjusted earnings per share guidance for fiscal 2025 has been reaffirmed at approximately $17.00
  • It also confirmed the FY25 Insurance segment benefit ratio guidance range in the 90.1-90.5% range
ADVERTISEMENT